Class information for:
Level 1: ORTHOKINE//MOL ORTHOPAED//UNITE RECH IMMUNOPATHOL MALAD TUMORALES AUTOIMM

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
18094 504 45.8 88%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1511 6960 COLLAGEN INDUCED ARTHRITIS//SECT MED INFLAMMAT//INTERLEUKIN 1 RECEPTOR ANTAGONIST

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ORTHOKINE Author keyword 6 80% 1% 4
2 MOL ORTHOPAED Address 5 23% 4% 21
3 UNITE RECH IMMUNOPATHOL MALAD TUMORALES AUTOIMM Address 4 67% 1% 4
4 UP EA 3408 Address 3 30% 1% 7
5 AUTOLOGOUS CONDITIONED SERUM ACS Author keyword 2 67% 0% 2
6 SERV CLIN IMMUNORHUMATOL Address 2 67% 0% 2
7 SERV IMMUNORHUMATOL Address 2 14% 2% 12
8 MOL ORTHOPED Address 2 26% 1% 5
9 CTLA4 FASL Author keyword 1 50% 0% 2
10 GRP RECH IMMUNOPATHOL IMMUNOINTERVENT Address 1 50% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 ORTHOKINE 6 80% 1% 4 Search ORTHOKINE Search ORTHOKINE
2 AUTOLOGOUS CONDITIONED SERUM ACS 2 67% 0% 2 Search AUTOLOGOUS+CONDITIONED+SERUM+ACS Search AUTOLOGOUS+CONDITIONED+SERUM+ACS
3 CTLA4 FASL 1 50% 0% 2 Search CTLA4+FASL Search CTLA4+FASL
4 SYNOVIAL NEOVASCULARIZATION 1 100% 0% 2 Search SYNOVIAL+NEOVASCULARIZATION Search SYNOVIAL+NEOVASCULARIZATION
5 CARTILAGE DESTRUCTION 1 18% 1% 7 Search CARTILAGE+DESTRUCTION Search CARTILAGE+DESTRUCTION
6 AUTOLOGOUS CONDITIONED SERUM 1 29% 1% 4 Search AUTOLOGOUS+CONDITIONED+SERUM Search AUTOLOGOUS+CONDITIONED+SERUM
7 CONTRALATERAL EFFECT 1 24% 1% 4 Search CONTRALATERAL+EFFECT Search CONTRALATERAL+EFFECT
8 PG201 1 40% 0% 2 Search PG201 Search PG201
9 BIOACTIVE BIOMATERIAL 1 50% 0% 1 Search BIOACTIVE+BIOMATERIAL Search BIOACTIVE+BIOMATERIAL
10 CHEMOKINS 1 50% 0% 1 Search CHEMOKINS Search CHEMOKINS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 VIRAL IL 10 18 42% 7% 33
2 INTRAARTICULAR EXPRESSION 17 75% 2% 12
3 RABBIT KNEES 10 44% 4% 18
4 PLASMID ENCODING INTERLEUKIN 4 9 83% 1% 5
5 RECEPTOR ANTAGONIST CDNA 6 80% 1% 4
6 SECRETE IL 4 6 80% 1% 4
7 RECOMBINANT ADENOASSOCIATED VECTOR 6 71% 1% 5
8 RECEPTOR ANTAGONIST PROTEIN 5 24% 3% 17
9 EARLY EXPERIMENTAL OSTEOARTHRITIS 4 47% 1% 7
10 IPSILATERAL PAW 4 75% 1% 3

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Arthritis gene therapy and its tortuous path into the clinic 2013 14 64 58%
Gene therapy for arthritis 2003 55 90 69%
Gene therapy for arthritis - What next? 2006 29 148 67%
Cytokine-Modulating Strategies and Newer Cytokine Targets for Arthritis Therapy 2015 2 111 12%
Uncoupling of inflammatory and destructive mechanisms in arthritis 2001 62 26 54%
Gene therapy for rheumatic diseases 1999 94 74 47%
Gene therapeutic approaches-transfer in vivo 2006 37 122 37%
Use of autologous conditioned serum (Orthokine (R)) for the treatment of the degenerative osteoarthritis of the temporomandibular joint. Review of the literature 2013 1 15 67%
Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients? 2004 17 111 64%
Gene therapy of the rheumatic diseases: 1998 to 2008 2009 18 94 50%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MOL ORTHOPAED 5 23% 4.2% 21
2 UNITE RECH IMMUNOPATHOL MALAD TUMORALES AUTOIMM 4 67% 0.8% 4
3 UP EA 3408 3 30% 1.4% 7
4 SERV CLIN IMMUNORHUMATOL 2 67% 0.4% 2
5 SERV IMMUNORHUMATOL 2 14% 2.4% 12
6 MOL ORTHOPED 2 26% 1.0% 5
7 GRP RECH IMMUNOPATHOL IMMUNOINTERVENT 1 50% 0.4% 2
8 LEONARD DE VINCI MED 1 100% 0.4% 2
9 UP EA 2361 1 50% 0.4% 2
10 WILLIAM HARVEY BONE JOINT UNIT 1 100% 0.4% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000203802 FIBROBLAST LIKE SYNOVIOCYTES//BEREICH MOL MED MUSKULOSKELETALEN SYST//ABORATING MOL BIOL NOVEL THER EUT STRA
2 0.0000186891 SKELETAL BIOTECH//FACILITATED ENDOGENOUS REPAIR//SKELETAL BIOTECHNOL
3 0.0000164633 HANS WILSDORF//CLIN IMMUNOL UNITHANS WILSDORF//IMMUNOL ALLERGYCLIN IMMUNOL UNIT
4 0.0000153744 SECT MED INFLAMMAT//COLLAGEN INDUCED ARTHRITIS//MED INFLAMMAT
5 0.0000118337 AGGRECANASE//ADAMTS//ADAMTS 5
6 0.0000104673 INTERLEUKIN 1 RECEPTOR ANTAGONIST//IL 1 RECEPTOR ANTAGONIST//LYMPHOKINE RESEARCH
7 0.0000100389 INTRA ARTICULAR DRUG DELIVERY//PARENTERAL DEPOTS//ROTATING DIALYSIS CELL
8 0.0000098412 PGLA MICROSPHERES//POLIKLIN REUMATOL//PROTEOGLYCAN SYNTHESIS
9 0.0000096182 DIACEREIN//DIACERHEIN//DIACETYLRHEIN
10 0.0000095382 PRECLIN SAFETY S//NONCLINICAL TOXICITY//KAWASHIMA